Erin N Kane is a director of Chemours Company.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 24 | ASIX AdvanSix | Common Stock, par value $0.01 | Grant | Acquire A | No | No | 0 | 63,962 | 0.00 | 562,755 |
28 Feb 24 | ASIX AdvanSix | Common Stock, par value $0.01 | Payment of exercise | Dispose F | No | No | 27.36 | 54,328 | 1.49 mm | 498,793 |
28 Feb 24 | ASIX AdvanSix | Common Stock, par value $0.01 | Grant | Acquire A | No | No | 0 | 106,213 | 0.00 | 553,121 |
24 Feb 24 | ASIX AdvanSix | Common Stock, par value $0.01 | Payment of exercise | Dispose F | No | No | 27.81 | 13,596 | 378.10 k | 446,908 |
29 Dec 23 | CC Chemours | Stock Units Common Stock | Grant | Acquire A | No | No | 31.54 | 792.644 | 25.00 k | 10,261.932 |
29 Sep 23 | CC Chemours | Stock Units Common Stock | Grant | Acquire A | No | No | 28.05 | 891.266 | 25.00 k | 9,392.151 |
30 Jun 23 | CC Chemours | Stock Units Common Stock | Grant | Acquire A | No | No | 36.89 | 677.69 | 25.00 k | 8,434.679 |